Standex International (NYSE: SXI) insider transactions
In the twelve months to 10 November 2026, executives and directors of Standex International reported 22 open-market sales of 37,570 shares ($10.2m) and 3 open-market purchases of 2,045 shares ($502,328), by 9 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 4 November 2026 | Cannon Charles H JR | Director | Open-market sale | −908 | $259.03 | 1,989 | Form 4 |
| 2 November 2026 | Chorman Thomas E | Director | Open-market sale, 10b5-1 plan | −50 | $250.00 | 12,833 | Form 4 |
| 22 October 2026 | Nemeth Andy L | Director | Grant or award | +617 | — | 9,256 | Form 4 |
| 22 October 2026 | Hickey Michael A | Director | Grant or award | +617 | — | 13,522 | Form 4 |
| 22 October 2026 | Davenport Robin J | Director | Grant or award | +617 | — | 5,328 | Form 4 |
| 22 October 2026 | Chorman Thomas E | Director | Grant or award | +617 | — | 12,883 | Form 4 |
| 22 October 2026 | Cannon Charles H JR | Director | Grant or award | +617 | — | 2,897 | Form 4 |
| 22 October 2026 | Edwards Jeffrey S | Director | Grant or award | +617 | — | 15,041 | Form 4 |
| 20 October 2026 | Dunbar David A. | President/CEO/Chairman | Gift | −11,305 | — | 1 | Form 4 |
| 20 October 2026 | Dunbar David A. | President/CEO/Chairman | Gift | +11,305 | — | 87,278 | Form 4 |
| 1 October 2026 | Chorman Thomas E | Director | Open-market sale, 10b5-1 plan | −50 | $271.39 | 12,266 | Form 4 |
| 30 September 2026 | Arets Max | VP; Chief Information Officer | Grant or award | +11 | $232.10 | 1,652 | Form 4 |
| 30 September 2026 | Rangel Danielle | VP & Chief Accounting Officer | Grant or award | +6 | $232.10 | 339 | Form 4 |
| 4 September 2026 | Arets Max | VP; Chief Information Officer | Open-market purchase | +3 | $274.20 | 1,599 | Form 4 |
| 4 September 2026 | Arets Max | VP; Chief Information Officer | Open-market purchase | +42 | $273.94 | 1,641 | Form 4 |
| 1 September 2026 | Chorman Thomas E | Director | Open-market sale, 10b5-1 plan | −50 | $284.89 | 12,316 | Form 4 |
| 31 August 2026 | Dunbar David A. | President/CEO/Chairman | Open-market sale, 10b5-1 plan | −4,000 | $290.81 | 84,973 | Form 4 |
| 31 August 2026 | Dunbar David A. | President/CEO/Chairman | Open-market sale, 10b5-1 plan | −9,000 | $290.82 | 75,973 | Form 4 |
| 24 August 2026 | Sarcevic Ademir | Vice President/CFO/Treasurer | Open-market sale | −2,300 | $306.13 | 7,486 | Form 4 |
| 24 August 2026 | Glass Alan J | Vice President | Open-market sale | −1,391 | $303.19 | 22,723 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Standex International page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.